Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1,329 INR | +1.78% | +2.83% | -2.01% |
06/05 | Caplin Point Laboratories Gets Colombian Drug Regulator's Approval for Soft Gel Capsules Unit in India | MT |
16/04 | Caplin Point Arm Gets US FDA Final Nod for Ofloxacin Ophthalmic Solution | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-2.01% | 118.73Cr | |
+22.69% | 4.38TCr | |
+25.56% | 2.3TCr | |
+18.96% | 1.53TCr | |
+8.91% | 1.37TCr | |
+42.72% | 1.2TCr | |
-7.49% | 697.64Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+13.26% | 559.02Cr |
- Stock Market
- Equities
- CAPLIPOINT Stock
- News Caplin Point Laboratories Limited
- Transcript : Caplin Point Laboratories Limited, Q3 2024 Earnings Call, Feb 09, 2024